Amplatzer™Amulet™ Post-Market Study (Amulet™PMS) (Amulet™PMS)
Amplatzer™Amulet™ Observational Post-Market Study
Sponsor: Abbott Medical Devices
Listed as NCT02447081, this observational or N/A phase trial focuses on Atrial Fibrillation and Stroke and remains completed. Sponsored by Abbott Medical Devices, it has been updated 12 times since 2015, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jan 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Mar 2019 — Jan 2020 [monthly]
Completed
-
Feb 2019 — Mar 2019 [monthly]
Completed
-
Dec 2018 — Feb 2019 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amiens, France , Bad Berka, Germany , Bad Segeberg, Germany , Badajoz, Spain , Baggiovara, Italy , Barcelona, Spain , Berlin, Germany , Bonn, Germany , Brighton, United Kingdom , Caserta, Italy and 34 more locations